par
Gus Iversen, Editor in Chief | August 27, 2025
Nusano has officially opened its new 190,000-square-foot radioisotope production facility in West Valley City, Utah, marking a step forward in domestic supply of medical and industrial isotopes.
The site is designed to produce over 40 different radioisotopes, with production expected to begin in late 2025.
Utah Governor Spencer Cox attended the ribbon-cutting ceremony, calling the facility “a perfect example” of the state’s leadership in life sciences and advanced manufacturing. “This work will deliver the radioisotopes needed for cancer treatment, advanced technologies, and national security,” Cox said.
Ad Statistics
Times Displayed: 17108
Times Visited: 38 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money.
The privately held company, headquartered in Utah, has developed a linear accelerator-based platform that enables the simultaneous production of multiple isotopes. According to the company, this approach offers a more efficient alternative to legacy systems and aims to ease ongoing shortages that have impacted radiopharmaceutical development.
“From our world class production facility in Utah, we will make radioisotopes in quantities and varieties unsurpassed by older methods,” said Chris Lowe, CEO of Nusano. “This will help address supply chain bottlenecks, support domestic manufacturing, and deliver life-changing radioisotope supplies needed for cancer care.”
Nusano has begun accepting reservations and entering into supply agreements for its planned output. The facility will be capable of producing up to 12 different radioisotopes at once, including alpha-emitters used in both therapeutic applications and nuclear-powered battery systems.
Dr. Howard Lewin, co-founder and chief product development officer, noted that researchers often lack access to the most suitable isotopes for clinical development. “Our Utah facility can produce up to 12 different radioisotopes simultaneously. This means we can meet the existing needs of drugmakers and at the same time enable tomorrow’s clinical breakthroughs,” he said.
In addition to healthcare, Nusano aims to support applications in aerospace, defense, and energy through its production of long-lived radioisotopes used in compact nuclear batteries.
